PRECISION BIOSCIENCES INC
Total Trades
92
Buys
19
Sells
36
Largest Trade
N/A
Insiders
10
Institutional Funds
47
Inst. Value
$1M+
Activist Filings
37
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Amoroso Michael | President and CEO | EXERCISE | N/A | 115K | — | Jan 22, 2026 |
| Amoroso Michael | President and CEO | SELL | $100K–$500K | 35K | $4.17 | Jan 22, 2026 |
| Scimeca Dario | General Counsel an… | SELL | $15K–$50K | 9K | $4.03 | Jan 22, 2026 |
| Scimeca Dario | General Counsel an… | EXERCISE | N/A | 25K | — | Jan 22, 2026 |
| Kelly John Alexander | CFO | SELL | $50K–$100K | 15K | $4.03 | Jan 22, 2026 |
| Kelly John Alexander | CFO | EXERCISE | N/A | 44K | — | Jan 22, 2026 |
| SMITH J. JEFFERSON | Chief Research Off… | EXERCISE | N/A | 29K | — | Jan 22, 2026 |
| SMITH J. JEFFERSON | Chief Research Off… | SELL | $15K–$50K | 10K | $4.03 | Jan 22, 2026 |
| Germano Geno J | Director | BUY | $1K–$15K | 3K | $4.72 | Dec 17, 2025 |
| Frankel Stanley | Director | BUY | $1K–$15K | 3K | $4.70 | Dec 17, 2025 |
| Brown Melinda | Director | BUY | $1K–$15K | 1K | $4.97 | Dec 17, 2025 |
| Kelly John Alexander | CFO | SELL | $1K–$15K | 1K | $6.49 | Nov 4, 2025 |
| Kelly John Alexander | CFO | EXERCISE | N/A | 4K | — | Nov 4, 2025 |
| Scimeca Dario | General Counsel an… | SELL | $1K–$15K | 665 | $6.49 | Nov 4, 2025 |
| Scimeca Dario | General Counsel an… | EXERCISE | N/A | 2K | — | Nov 4, 2025 |
| Amoroso Michael | President and CEO | EXERCISE | N/A | 9K | — | Nov 4, 2025 |
| Amoroso Michael | President and CEO | SELL | $15K–$50K | 3K | $6.49 | Nov 4, 2025 |
| Frankel Stanley | Director | BUY | $1K–$15K | 3K | $4.97 | Sep 30, 2025 |
| Brown Melinda | Director | BUY | $1K–$15K | 1K | $4.89 | Sep 24, 2025 |
| Kelly John Alexander | CFO | SELL | $50K–$100K | 15K | $4.26 | Jul 8, 2025 |
| Brown Melinda | Director | BUY | $1K–$15K | 2K | $4.14 | Jun 27, 2025 |
| Buehler Kevin | Director | BUY | $15K–$50K | 5K | $4.16 | Jun 27, 2025 |
| Buehler Kevin | Director | BUY | $15K–$50K | 5K | $4.67 | Mar 28, 2025 |
| Brown Melinda | Director | BUY | $1K–$15K | 2K | $4.75 | Mar 28, 2025 |
| Germano Geno J | Director | BUY | $15K–$50K | 3K | $5.30 | Mar 27, 2025 |
| Amoroso Michael | President and CEO | SELL | $1K–$15K | 964 | $5.56 | Mar 25, 2025 |
| Amoroso Michael | President and CEO | EXERCISE | N/A | 3K | — | Mar 25, 2025 |
| Scimeca Dario | General Counsel an… | SELL | $15K–$50K | 9K | $4.79 | Jan 23, 2025 |
| Scimeca Dario | General Counsel an… | EXERCISE | N/A | 25K | — | Jan 23, 2025 |
| Amoroso Michael | President and CEO | SELL | $100K–$500K | 37K | $4.67 | Jan 23, 2025 |
| Amoroso Michael | President and CEO | EXERCISE | N/A | 115K | — | Jan 23, 2025 |
| SMITH J. JEFFERSON | Chief Research Off… | EXERCISE | N/A | 29K | — | Jan 23, 2025 |
| SMITH J. JEFFERSON | Chief Research Off… | SELL | $15K–$50K | 10K | $4.79 | Jan 23, 2025 |
| Germano Geno J | Director | BUY | $15K–$50K | 4K | $4.49 | Jan 2, 2025 |
| Buehler Kevin | Director | BUY | $15K–$50K | 4K | $4.88 | Dec 31, 2024 |
| Kelly John Alexander | CFO | BUY | $1K–$15K | 2K | $4.75 | Dec 31, 2024 |
| Brown Melinda | Director | BUY | $1K–$15K | 3K | $4.55 | Dec 30, 2024 |
| Kelly John Alexander | CFO | BUY | $15K–$50K | 3K | $6.76 | Nov 21, 2024 |
| Scimeca Dario | General Counsel an… | SELL | $1K–$15K | 588 | $8.19 | Nov 6, 2024 |
| Scimeca Dario | General Counsel an… | EXERCISE | N/A | 2K | — | Nov 6, 2024 |
| Amoroso Michael | President and CEO | SELL | $15K–$50K | 3K | $8.19 | Nov 6, 2024 |
| Amoroso Michael | President and CEO | EXERCISE | N/A | 9K | — | Nov 6, 2024 |
| Scimeca Dario | General Counsel an… | EXERCISE | N/A | 301 | — | Jun 11, 2024 |
| Scimeca Dario | General Counsel an… | SELL | $1K–$15K | 93 | $11.79 | Jun 11, 2024 |
| SMITH J. JEFFERSON | Chief Research Off… | EXERCISE | N/A | 163 | — | Jun 11, 2024 |
| SMITH J. JEFFERSON | Chief Research Off… | SELL | <$1K | 50 | $11.79 | Jun 11, 2024 |
| Scimeca Dario | General Counsel an… | EXERCISE | N/A | 918 | — | May 3, 2024 |
| Scimeca Dario | General Counsel an… | SELL | $1K–$15K | 272 | $10.32 | May 3, 2024 |
| SMITH J. JEFFERSON | Chief Research Off… | SELL | $1K–$15K | 154 | $10.32 | May 3, 2024 |
| SMITH J. JEFFERSON | Chief Research Off… | EXERCISE | N/A | 519 | — | May 3, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 47 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Empery Asset Management, LP | 2.2M | $1M+ | SH |
| Aberdeen Group plc | 2.1M | $1M+ | SH |
| Octagon Capital Advisors LP | 1.9M | $1M+ | SH |
| Bleichroeder LP | 1.7M | $1M+ | SH |
| Alyeska Investment Group, L.P. | 798K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 396K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 326K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 182K | $500K+ | SH |
| COMMONWEALTH EQUITY SERVICES, LLC | 93K | $100K–$500K | SH |
| Quarry LP | 68K | $100K–$500K | SH |
| BlackRock, Inc. | 62K | $100K–$500K | SH |
| OMERS ADMINISTRATION Corp | 61K | $100K–$500K | SH |
| STATE STREET CORP | 59K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 56K | $100K–$500K | SH |
| GSA CAPITAL PARTNERS LLP | 39K | $100K–$500K | SH |
| Point72 Asset Management, L.P. | 30K | $100K–$500K | SH |
| DIMENSIONAL FUND ADVISORS LP | 21K | $50K–$100K | SH |
| MARSHALL WACE, LLP | 20K | $50K–$100K | SH |
| Velan Capital Investment Management LP | 20K | $50K–$100K | SH |
| Miller Financial Services LLC | 15K | $50K–$100K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
0.0%
0 shares
SC 13G/A · Feb 17, 2026
4.1%
994K shares
SC 13G/A · Feb 13, 2026
8.2%
1.9M shares
SC 13G · Feb 10, 2026
10.0%
2.3M shares
SC 13G · Jan 27, 2026
8.9%
2.1M shares
SC 13G · Jan 22, 2026
10.0%
2.3M shares
SC 13G/A · Nov 14, 2025
8.8%
1.0M shares
SC 13G/A · Aug 14, 2025
9.3%
1.1M shares
SC 13G · Aug 14, 2025
9.7%
1.1M shares
SC 13G/A · Aug 6, 2025
0.0%
0 shares
SC 13G/A · Aug 6, 2025
3.7%
414K shares
SC 13G/A · May 15, 2025
6.4%
673K shares
Highbridge Capital Management, LLC
SC 13G/A · Apr 25, 2025
3.7%
406K shares
SC 13G · Mar 26, 2025
8.8%
920K shares
SC 13G · Mar 18, 2025
5.2%
395K shares
SC 13G/A · Feb 14, 2025
6.6%
521K shares
SC 13G/A · Feb 14, 2025
0.0%
0 shares
SC 13G · Feb 14, 2025
10.0%
766K shares
SC 13G/A · Feb 12, 2025
5.4%
414K shares
SC 13G/A · Nov 14, 2024
5.9%
426K shares
SC 13G/A · Nov 14, 2024
8.6%
623K shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Nov 14, 2024
9.7%
702K shares
Highbridge Capital Management, LLC
SC 13G · Nov 14, 2024
5.3%
406K shares
SC 13G · Mar 18, 2024
7.1%
467K shares
SC 13G · Mar 14, 2024
7.9%
500K shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Mar 11, 2024
8.0%
511K shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Capital World Investors 95-1411037
SC 13G/A · Feb 12, 2024
4.2%
5.1M shares
SC 13G · Feb 27, 2023
7.3%
8.1M shares
SC 13G/A · Feb 14, 2023
3.4%
3.8M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 13, 2023
6.1%
6.7M shares
Eli Lilly and Company 35-0470950
SC 13G/A · Jan 27, 2023
3.4%
3.8M shares
SC 13G/A · Aug 31, 2022
3.9%
4.3M shares
SC 13G · Jul 8, 2022
2.4%
2.4M shares
SC 13G · Jul 1, 2022
5.9%
5.8M shares
SC 13G · Jun 27, 2022
16.6%
12.4M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 11, 2022
7.0%
4.3M shares